LOX and colorectal cancer: Cohesive scientific evidence from molecular, animal, and human investigations supports the hypothesis that sustained constitutive overexpression of COX and LOX is a ubiquitous driver of colorectal carcinogenesis, and reciprocally, that blockade of these major inflammatory cascades has strong potential for colorectal cancer prevention and therapy.